Medical Assistance
Receive guidance from the first consultation through the entire hospitalization process.
0
Why are the research and testimonies of Vitamin B17 so hush-hush?
- 1 people answered
0 Vote
1 Contributor
1786 Views 
0 Saved 0 Vote 1 Contributor1786 Views 0 SavedYou might also be interested in
Do you have a blue vein in your breast? If so, it may be nothing but a cosmetic problem. In most of the cases are harmless and tend to fade by themselves. Sometimes, however, blue veins in breasts can indicate the presence of an underlying medical condition. It is normal for you to worry if you not....
It completely depends on the situation. In Kyphoplasty, either a spine surgeon or an interventional radiologist tries to treat a vertebral fracture using surgical cement. It effectively reduces the pain. In case of a cancer patient, the process accompanies radiofrequency ablation to remove cancer ti....
Generally, women having their routine mammogram will receive a letter within one month with normal results. But if the doctor finds something suspicious, they’ll call you back, mostly within just 5 days, to take fresh pictures or other tests. Yes, that call may seem to be scary, but a suspicious fin....
Nidii Berwal
Vitamin B17 is not actually a vitamin. Vitamins are essential for human health. B17 is a poison also known as amygdalin as well as drugs. Amygdalin is broken down into cyanide, which is an incredibly toxic substance. There is zero reason to use it to treat cancer. There is no scientific evidence is works. It’s one of the clearest cases of snake oil medicine. This drug is a cyanogenic glycoside, a conjugate of cyanide and a sugar. They are a common type of chemical many plants produce for chemical self-defense: to keep their seeds from getting chewed up (apples, cherries, apricots, raw lima beans, bitter almonds) or seedlings eaten (sorghum) or roots eaten (cassava, processed to remove most of the cyanide in order to make tapioca). It was first experimented by former Soviet Union scientist in the 50’s of the 20th century and abandoned. The interest re-emerged in USA after Erns T. Krebs patented a method to synthesize a simplified version of the compound and started promoting it as treatment for cancer, it was utilized in many patients off-code until the FDA banned it.